Northwest Biotherapeutics reported $-14.32M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Agenus USD 14.4M 19.26M Dec/2025
AstraZeneca USD 7.11B 4.14B Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Celldex Therapeutics USD -84.44M 2.72M Mar/2026
Eisai JPY -10.31B 30.35B Mar/2026
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Merck USD -1.88B 8.12B Mar/2026
Northwest Biotherapeutics USD -14.32M 822K Sep/2025
Pfizer USD 4.99B 340M Mar/2026
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025